Literature DB >> 10025594

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.

M G Sabbadini1, A A Manfredi, E Bozzolo, L Ferrario, C Rugarli, R Scorza, L Origgi, M Vanoli, O Gambini, L Vanzulli, D Croce, A Campana, C Messa, F Fazio, A Tincani, G Anzola, R Cattaneo, A Padovani, R Gasparotti, R Gerli, R Quartesan, M Piccirilli, A Farsi, E Emmi, A Passaleva.   

Abstract

OBJECTIVE: To verify whether features of CNS involvement can be detected in SLE patients without overt neuropsychiatric manifestations.
METHODS: 114 SLE patients who had never received a diagnosis of neuropsychiatric lupus (never-NPSLE) were studied and compared to 65 SLE patients with known neuropsychiatric involvement (NPSLE). The study relied on evaluation of neurocognitive functions by means of a battery of neuropsychological tests, on psychiatric and neuropsychological assessments and on neuroimaging studies (computed tomography, magnetic resonance, single photon emission computed tomography (SPECT)).
RESULTS: Clinical features, including disease duration/activity and pharmacological therapy, of never-NPSLE and NPSLE patients were similar. Short-term and long-term memory, visuo-spatial and verbal information processing were similarly compromised in never-NPSLE and in NPSLE patients; only attention was significantly more compromised in NPSLE patients. Psychiatric morbidity was higher than expected in never-NPSLE patients, although less than in the control neuropsychiatric group. Ischemic lesions, multiple small high intensity lesions and cortical atrophy, detected by CT and MR scans, as well as abnormal SPECT were also frequently detected in never-NPSLE patients. Interestingly, left parietal and occipital area hypoperfusion by SPECT was significantly more frequent in the patients with impaired visuo-spatial intelligence and short-term memory.
CONCLUSIONS: Most abnormalities detected by available diagnostic tools and characteristics of neuropsychiatric SLE are also present in non-symptomatic patients. They may derive from an unexpected widespread involvement of the CNS and are not per se sufficient, in the absence of clinical manifestations, for a diagnosis of neuropsychiatric SLE.

Entities:  

Mesh:

Year:  1999        PMID: 10025594     DOI: 10.1191/096120399678847344

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  21 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Cerebral angioedema associated with enalapril.

Authors:  Eric Decloedt; Rob Freercks; Gary Maartens
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

3.  Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.

Authors:  Amy E Ramage; Peter T Fox; Robin L Brey; Shalini Narayana; Matthew D Cykowski; Mohammad Naqibuddin; Margaret Sampedro; Stephen L Holliday; Crystal Franklin; Daniel J Wallace; Michael H Weisman; Michelle Petri
Journal:  Arthritis Rheum       Date:  2011-10

Review 4.  Integrative neuroscience approach to neuropsychiatric lupus.

Authors:  Patricio T Huerta; Elizabeth L Gibson; Carson Rey; Tomás S Huerta
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

5.  Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus.

Authors:  Patricia Katz; Laura Julian; Mary C Tonner; Jinoos Yazdany; Laura Trupin; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

6.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

Review 7.  Neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  David Hermosillo-Romo; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 8.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

9.  Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.

Authors:  Michelle Petri; Mohammad Naqibuddin; Kathryn A Carson; Daniel J Wallace; Michael H Weisman; Stephen L Holliday; Margaret Sampedro; Shalini Narayana; Peter T Fox; Crystal Franklin; Patricia A Padilla; Robin L Brey
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

10.  Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study.

Authors:  Yasuhiro Katsumata; Masayoshi Harigai; Yasushi Kawaguchi; Chikako Fukasawa; Makoto Soejima; Tokiko Kanno; Katsuji Nishimura; Takayuki Yamada; Hisashi Yamanaka; Masako Hara
Journal:  BMC Musculoskelet Disord       Date:  2010-01-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.